In breast cancer specifically, preclinical studies suggest that this could be attributed to oncogenic paracrine signaling, whereby tumor cell-derived CSF-1 facilitates the recruitment of CSF-1R expressing polarized macrophages into the tumor microenvironment, thereby promoting angiogenesis, tumor cell migration, and invasion [9,10,11,12,13]. The gene discussed is CSF1R; the disease is breast cancer.